RHON-KLINIKUM AG has reported a stable business performance for the first half of 2026, with consolidated revenue reaching EUR 863.6 million, slightly above the previous year's level of EUR 833.5 million. EBITDA improved to EUR 57.0 million from EUR 46.7 million, and consolidated profit rose to EUR 22.5 million compared to EUR 14.7 million in the same period last year. The company treated 513,700 patients on an outpatient and inpatient basis, a 9% increase from 471,295 in H1 2025.
The results were significantly impacted by immediate transformation costs established until November 2026 to offset higher personnel and material costs from previous years. Despite these challenges, the company continues to invest in expanding regional health networks, which are seen as vital for the future of healthcare delivery. For instance, Universitatsklinikum Marburg and the pulmonary clinic Lungenfachklinik Immenhausen have formed a strategic partnership to improve lung patient care. Additionally, the newly opened child protection emergency service at the RHON-KLINIKUM Frankfurt (Oder) site, along with cooperation agreements with local authorities, aims to ensure coordinated help for children and adolescents.
Dr. Gunther K. WeiB, member of the Board of Management, emphasized the importance of regional networks: “Regional networks form a vital and essential part of any future healthcare system. Rigid sectoral boundaries make it more difficult to provide patients with the care they need and saddle our healthcare system with unnecessary costs. It is only when general practitioners, specialists, medical facilities, nurses and therapists work together as a team that we can pool our resources efficiently.”
However, the company also voiced concerns about recent legislative changes. Dr. Stefan Stranz, another board member, criticized the Statutory Health Insurance Contribution Rate Stabilization Act, stating that it “imposes further burdens on hospitals. Instead of reducing bureaucracy and refocusing on patient care, the reform saddles already overburdened hospitals with even more documentation requirements, excessive budget cuts, and financial risks.”
Looking ahead, RHON-KLINIKUM AG expects full-year revenues of EUR 1.7 billion, within a range of plus or minus 5%, and EBITDA between EUR 110 million and EUR 125 million. The company also anticipates a moderate improvement in non-financial performance indicators such as number of cases and cost weights. However, the forecast is subject to significant uncertainties due to ongoing legislative processes, including the Hospital Reform Adjustment Act and the SHI Contribution Rate Stabilisation Act, which aim to enhance quality and efficiency but may increase financial pressure on hospitals in the short term.
The company's ability to maintain stability amid these reforms underscores the importance of strategic investments in regional healthcare networks and the need for collaborative approaches to overcome sectoral barriers. As the healthcare landscape evolves, RHON-KLINIKUM AG's focus on integrating care across providers will be crucial for ensuring comprehensive and high-quality patient care, especially in rural areas.
